Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT

Yang Lu

doi:10.1097/RLU.0000000000002706

Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT

Yang Lu

Nuclear Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further ⁶⁸Ga-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.

Original language	English (US)
Pages (from-to)	914-915
Number of pages	2
Journal	Clinical nuclear medicine
Volume	44
Issue number	11
DOIs	https://doi.org/10.1097/RLU.0000000000002706
State	Published - Nov 1 2019

Keywords

DOTATATE
FDG
PET/CT
carcinoid
lung cancer
multiple myeloma
neuroendocrine tumor

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000002706

Cite this

@article{84d5f3f8377b4abcb14c72d77e998b8a,

title = "Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT",

abstract = "A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further 68Ga-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.",

keywords = "DOTATATE, FDG, PET/CT, carcinoid, lung cancer, multiple myeloma, neuroendocrine tumor",

author = "Yang Lu",

year = "2019",

month = nov,

day = "1",

doi = "10.1097/RLU.0000000000002706",

language = "English (US)",

volume = "44",

pages = "914--915",

journal = "Clinical nuclear medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT

AU - Lu, Yang

PY - 2019/11/1

Y1 - 2019/11/1

N2 - A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further 68Ga-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.

AB - A 69-year-old man with recurrent multiple myeloma underwent FDG PET/CT evaluation. A pulmonary nodule without higher-than-background FDG avidity was later biopsied as a low-grade neuroendocrine tumor. On further 68Ga-DOTATATE PET/CT evaluation of patient's neuroendocrine tumor, the lytic myeloma lesions revealed only mild DOTATATE avidity while the primary pulmonary neuroendocrine tumor showed intense DOTATATE uptake. The distinct imaging characteristics of different primary malignancies correlated with their underlying different pathology.

KW - DOTATATE

KW - FDG

KW - PET/CT

KW - carcinoid

KW - lung cancer

KW - multiple myeloma

KW - neuroendocrine tumor

UR - http://www.scopus.com/inward/record.url?scp=85072992253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072992253&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002706

DO - 10.1097/RLU.0000000000002706

M3 - Article

C2 - 31306189

AN - SCOPUS:85072992253

SN - 0363-9762

VL - 44

SP - 914

EP - 915

JO - Clinical nuclear medicine

JF - Clinical nuclear medicine

IS - 11

ER -